One Scientist’s Journey to Accelerate Drug Discovery for COVID-19

Join Dr. Jerome Baudry, a molecular biophysics professor from The University of Alabama in Huntsville, as he pushes the accelerator on coronavirus-focused drug discovery. He’s studying compounds and elements that occur in nature and their application to drug development. Using HPE’s Sentinel supercomputer, available through Microsoft Azure — he’s researching these natural products’ efficacy against COVID-19 and sharing victories, setbacks and insights from the lab.

Dr. Jerome Baudry COVID-19: Mission Log 3

Mission Log 3:  Some good news from Dr. Baudry as they get closer to making recommendations for molecules to screen against COVID-19.  Another milestone with the help of HPE Cray Sentinel supercomputer.

May 18, 2020

Dr. Jerome Baudry COVID-19: Mission Log 2

Mission Log 2: Dr. Jerome Baudry provides an update on his initial testing on the Sentinel supercomputer in Azure, with surprising results. Follow along to hear how he and his team solved their first challenge and what their next step will be.

May 12, 2020

Dr. Jerome Baudry COVID-19: Mission Log 1

Mission Log 1: Join the Journey to Discovery, as Dr. Jerome Baudry focuses on developing computational models to identify which ones can counteract COVID-19.

May 8, 2020

Journey to Discovery: Follow one scientist’s mission to accelerate drug discovery for COVID-19

Dr. Jerome Baudry is focused on developing computational models to identify which ones can counteract COVID-19. As part of HPE’s broader COVID-19 response, they now have access to the HPE Sentinel supercomputer.

May 5, 2020

One scientist’s journey to accelerate drug discovery for COVID-19 using cloud-based supercomputing

Chronicling Dr. Jerome Baudry’s mission to fight COVID-19 – using HPE’s Sentinel supercomputer through the cloud - at The University of Alabama in Huntsville (UAH)

May 5, 2020